CC Small or few human trials. Promising, not proven. How we grade →Systematic review and meta-analysis · 53 observational studies
Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
J Campbell, S Bellman, M Stephenson, K Lisy. Ageing Research Reviews. 2017.
- In plain language
- Pooled observational data: people with diabetes on metformin had lower all-cause mortality than people without diabetes (HR 0.93) and than people on other diabetes drugs.
- Limits
- Observational studies with baseline differences the authors say could bias the result; later registry work did not reproduce it.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Metformin as an aging drug: what the evidence shows, and why the TAME trial has not started
- Source
- doi.org/10.1016/j.arr.2017.08.003 · PubMed 28802803
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.